Chair: Prof. Dr Raquel Duarte (Porto, Portugal)
Speakers: Dr Sonal Munsiff (New York, United States), Dr Jussi Saukkonen (Boston, United States), Dr Juan Espinosa-Pereiro (Barcelona, Spain), Dr Giovanni Fumagalli (Milano, Italy)

Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member

Translation available

Participants in this webinar can benefit from translation during the live event. The translation function can be found underneath the live event's video player; as many as 60 languages are available, with both subtitled and audio translation available. Please note that this is currently available for the live event only.

Learn more about this function.

Overview

The treatment of tuberculosis (TB) is evolving due to emerging drug-resistant strains, advancements in pharmacological options, and updated international guidelines. Clinicians require up-to-date knowledge to manage both drug-susceptible and drug-resistant TB effectively. The guideline integrates evidence-based recommendations to address gaps in diagnosis, treatment adherence, and case management. This webinar addresses the critical need for education on applying these updates in various clinical and public health contexts.

Article

ATS/ERS/IDSA/CDC Guidelines on treatment of drug-susceptible and drug-resistant tuberculosis. Accepted for publication January 2025.

Aims:

• To provide an overview of the updated clinical guidelines for treating drug-susceptible and drug-resistant TB.
• To discuss evidence-based treatment options and recommendations.
• To explore practical strategies for implementing the guidelines in diverse healthcare settings.
• To enhance decision-making skills through case-based interactive learning.

Topics:

1. Clinical approach to TB: Updates and changes in the new guidelines - Sonal Munsiff
   
2. Treatment options: evidence-based strategies for managing drug-susceptible and drug-resistant TB - Jussi Saukkonen
   
3. Expert insights: challenges and opportunities in implementing the guidelines - Sonal Munsiff, Jussi Saukkonen
   
4. Practical application: case-based examples and audience engagement - Juan Espinosa-Pereiro, Giovanni Fumagalli

Format

• One-hour webinar format: 45 minutes for presentations, followed by a 15-minute Q&A session.

Learning outcomes

Following this webinar, participants will be able to:

1. Describe the key updates in the treatment of drug-susceptible and drug-resistant TB.
2. Select appropriate treatment regimens based on evidence-based recommendations.
3. Recognise challenges in the implementation of guidelines and propose solutions.
4. Apply the guidelines effectively in clinical practice through real-world case scenarios.

CME credit

An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.

What is a webinar?

A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.